Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.8110
-0.0696 (-7.90%)
At close: Mar 17, 2026, 4:00 PM EDT
0.8200
+0.0090 (1.11%)
After-hours: Mar 17, 2026, 7:47 PM EDT
Citius Pharmaceuticals Market Cap
Citius Pharmaceuticals has a market cap or net worth of $18.15 million as of March 17, 2026. Its market cap has increased by 35.43% in one year.
Market Cap
18.15M
Enterprise Value
12.26M
1-Year Change
35.43%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since July 6, 2017, Citius Pharmaceuticals's market cap has decreased from $30.70M to $18.15M, a decrease of -40.89%. That is a compound annual growth rate of -5.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 18.10M | 12.42% |
| Dec 31, 2025 | 16.10M | -47.90% |
| Dec 31, 2024 | 30.90M | -74.31% |
| Dec 29, 2023 | 120.30M | 4.16% |
| Dec 30, 2022 | 115.50M | -48.64% |
| Dec 31, 2021 | 224.90M | 296.65% |
| Dec 31, 2020 | 56.70M | 92.20% |
| Dec 31, 2019 | 29.50M | 59.46% |
| Dec 31, 2018 | 18.50M | -42.19% |
| Dec 29, 2017 | 32.00M | 4.23% |
| Jul 6, 2017 | 30.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 20.24M |
| Allarity Therapeutics | 19.76M |
| Pasithea Therapeutics | 19.75M |
| IN8bio | 19.10M |
| FibroBiologics | 18.67M |
| Lexaria Bioscience | 18.21M |
| Traws Pharma | 17.58M |
| Lixte Biotechnology Holdings | 17.17M |